Page last updated: 2024-11-05

trientine and Epithelial Neoplasms

trientine has been researched along with Epithelial Neoplasms in 1 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, S1
Naing, A1
Fu, C1
Kuo, MT1
Kurzrock, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase I Study of Trientine and Carboplatin in Patients With Advanced Malignancies[NCT01178112]Phase 156 participants (Actual)Interventional2010-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for trientine and Epithelial Neoplasms

ArticleYear
Overcoming platinum resistance through the use of a copper-lowering agent.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:6

    Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cation Transport Proteins;

2012